"Total debt = $285M - $110M(Vimovo+Canada)=$175M , which $75M is senior secure convertible note with 2.5% interest and ARLZ could issue another $100M senior secure Note with 2.5% then company will emerge from BK with a nice pipeline (Toprol-XL , Zontivity , Fibicore and US right for Bezalip SR and Yosprala) Toprol keep bring cash and other drug could be licensed out and bring a lot of cash . This is a WIN-WIN GAME ! still Optimism. Happy new year!"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.